Susceptibility of staphylococci and enterococci to antimicrobial agents at different ward levels in four north European countries

References

• Hanberger, H, Monnet, DL, Nilsson, LE. Intensive care unit. In: IM Gould, van der Meer, JWM. Antibiotic Policies: Theory and Practice. New York: Kluwer Academic/ Plenum Publisher; 2004. p. 261–79.
   Google Scholar
• Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE, Jr, Archibald LK, et al. FC and Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Hospitals. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Clin Infect Dis 1999; 29: 245–52
   PubMed Web of Science ®Google Scholar
• Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. Correspondence. J Antimicrob Chemother 1997; 40: 135–6
   PubMed Web of Science ®Google Scholar
• Fitch L, Johnson AP. Reduced susceptibility to teicoplanin in a methicillin resistant strain of Staphylococcus aureus. Correspondence. J Antimicrob Chemother 1998; 41: 578
   PubMed Web of Science ®Google Scholar
• Price MF, McBride ME, Wolf JE, Jr. Prevalence of methicillin resistant Staphylococcus aureus in a dermatology outpatient population. South Med J 1998; 91: 369–71
   PubMed Web of Science ®Google Scholar
• Hsu J, Lanza DC, Kennedy DW. Antimicrobial resistance in bacterial chronic sinusitis. Am J Rhinol 1998; 12: 243–8
   PubMedGoogle Scholar
• Simonsen GS, Småbrekke L, Monnet DL, Sørensen TL, Møller JK, Kristinsson KG, et al. Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in 5 Nordic hospitals. J Antimicrob Chemother 2003; 51: 323–31
   PubMed Web of Science ®Google Scholar
• Barišic Z, Punda-Polic V. Antibiotic resistance among enterococcal strains isolated from clinical specimens. Short communication. Int J Antimicrob Agents 2000; 16: 65–8
   PubMed Web of Science ®Google Scholar
• Walsh TR, Bolmström A, Qwärnström A, Ho P, Wooton M, Howe RA, et al. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 2001; 39: 2439–44
   PubMed Web of Science ®Google Scholar
• Enterococci. E-test application sheet EAS 009 [online] 2005-05 [cited 2006 July 19]. Available from: Ab Biodisk, Solna Sweden: http://www.abbiodisk.com.
   Google Scholar
• SRGA: MIC breakpoints from SRGA [online] 2006 April 20 [cited 2006 April 26]. Available from: Swedish Reference Group for Antibiotics (SRGA) and its subcommittee on Methodology (SRGA-M). http://www.srga.org/MICTAB/MICTAB1.htlm, , and. http://www.srga.org//MICTAB/MICTAB2.htlm
   Google Scholar
• EUCAST clinical MIC breakpoints [online] 2006 January 31 and March 31 [cited 2006 April 12]. Available from the European Committee on Antimicrobial Susceptibility Testing: http://www.srga.org/eucastwt/MICTAB/index.htlm.
   Google Scholar
• Hanberger H, Hoffmann M, Lindgren S, Nilsson LE. High incidence of antibiotic resistance among bacteria in 4 intensive care units at a university hospital in Sweden. Scand J Infect Dis 1997; 29: 607–14
   PubMed Web of Science ®Google Scholar
• Erlandsson, C-M, Hanberger, H, Eliasson, I, Hoffmann, M, Isaksson, B, Lindgren, S, ., in the ICU study group of south-east Sweden, et al. Surveillance of antibiotic resistance in ICUs in south-east Sweden. Acta Anaesthesiol Scand 1999;43:815–20.
   PubMed Web of Science ®Google Scholar
• Hanberger H, Diekema D, Fluit A, Jones R, Struelens M, Spencer R, Wolff M. Surveillance of antibiotic resistance in European ICUs. J Hosp Infect 2001; 48: 161–76
   PubMed Web of Science ®Google Scholar
• Von Eiff C, Peters G. Comparative in vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci. J Antimicrob Chemother 1999; 43: 569–73
   PubMed Web of Science ®Google Scholar
• Diekema, DJ, Pfaller, MA, Schmitz, FJ, Smayevsky, J, Bell, J, Jones, RN, Beach, M, and, the SENTRY participants group. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the Western Pacific region for the SENTRY antimicrobial surveillance programme, 1997–1998. Clin Infect Dis 2001;32 (Suppl 2):114–32.
   PubMed Web of Science ®Google Scholar
• Agvald-Öhman C, Lund B, Hjelmqvist H, Hedin G, Struwe J, Edlund C. ICU stay promotes enrichment and dissemination of multiresistant coagulase negative staphylococcal strains. Scand J Infect Dis 2006; 38: 441–7
   PubMed Web of Science ®Google Scholar
• May J, Shannon K, King A, French G. Glycopeptide tolerance in Staphylococcus aureus. J Antimicrob Chemother 1998; 42: 189–97
   PubMed Web of Science ®Google Scholar
• Bobin-Dubreux S, Reverdy M-E, Nervi C, Rougier M, Bolmström A, Vandenesch F, Etienne J. Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative. Antimicrob Agents Chemother 2001; 45: 349–52
   PubMed Web of Science ®Google Scholar
• Del'Almo L, Cereda RF, Tosin I, Miranda EA, Sader HS. Antimicrobial susceptibility of coagulase negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides. Diagn Microbiol Infect Dis 1999; 34: 185–91
   PubMed Web of Science ®Google Scholar
• Cercenado E, García-Leoni ME, Díaz MD, Sánchez-Carrillo C, Catalán P, Bernaldo de Quirós JCL, Bouza E. Emergence of teicoplanin-resistant coagulase negative staphylococci. J Clin Microbiol 1996; 34: 1765–8
   PubMed Web of Science ®Google Scholar
• Woodford N, Johnson AP, Morrison D, Speller DC. Current perspectives on glycopeptide resistance. Clin Microbiol Rev 1995; 8: 585–615
   PubMed Web of Science ®Google Scholar
• Chomarat M, Espinouse D, Flandrois J-P. Coagulase negative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity. J Antimicrob Chemother 1991; 27: 475–80
   PubMed Web of Science ®Google Scholar
• Bertin M, Muller A, Bertrand X, Cornette C, Thouverez M, Talon D. Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase negative staphylococci. Eur J Clin Microbiol Infect Dis 2004; 23: 375–9
   PubMed Web of Science ®Google Scholar
• Scouthen, MA, Hoogkamp-Korstanje, JAA, Meis, JFG, Voss, A, and, the European VRE Study Group. Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 2000;19:816–22.
   PubMed Web of Science ®Google Scholar
• Torell E, Kühn I, Olsson-Liljequist B, Hæggman S, Hoffman B-M, Lindahl C, Burman LG. Clonality among ampicillin-resistant Enterococcus faecium isolates in Sweden and relationship with ciprofloxacin resistance. Clin Microbiol Infect 2003; 9: 1011–9
   PubMed Web of Science ®Google Scholar
• Jureen R, Top J, Mohn SC, Harthug S, Langeland N, Willems RJL. Molecular characterization of ampicillin-resistant Enterococcus faecium isolates from hospitalized patients in Norway. J Clin Microbiol 2003; 41: 2330–6
   PubMed Web of Science ®Google Scholar
• Leavis HL, Bonten MJM, Willems RJL. Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance. Curr Opin Microbiol 2006; 9: 454–60
   PubMed Web of Science ®Google Scholar
• EARSS: The EARSS annual report 2005 [online] 2006 Oct [cited 2007 Feb 27], Available from European Antimicrobial Resistance Surveillance Systems. http://www.rivm.nl/earss/results/Monitoring_reports/.
   Google Scholar
• Johnson AP, Warner M, Woodford N, Speller DCE, Livermore DM. Antibiotic resistance among enterococci causing endocardidtis in the UK: analysis of isolates referred to a reference laboratory. Paper. Br Med J 1998; 317: 629–30
   PubMed Web of Science ®Google Scholar
• Hällgren, A, Abednazari, H, Ekdahl, C, Hanberger, H, Nilsson, M, Samuelsson, A, ., and, the Swedish ICU Study Group, et al. Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems. J Antimicrob Chemother 2001;48:53–62.
   PubMed Web of Science ®Google Scholar